Stroke burden is substantially increasing but current therapeutic drugs are still far from ideal. Here we highlight the vast potential of staphylokinase as an efficient, fibrin-selective, inexpensive,…
Archives: Results
A new comprehensive review published in Journal of Stroke, written by STROKE BRNO members and our foreign collaborators brings updated information about currently available thrombolytics, strategies for…
Diseases with the highest burden for society such as stroke, myocardial infarction, pulmonary embolism, and others are due to blood clots. Preclinical and clinical techniques to study…
A unique project of cerebral artery models and processes associated with stroke was awarded in Brno Ph.D. talent competition organized by the South Moravian Center for International…
The ESO Angels Spirit of Excellence award is given to those who embody “perfection in stroke management” in their approach to patients, other hospital team members, and…
Together with the Office of the Government of the Czech Republic, Česká hlava is the annual announcer of the same name – the most prestigious Czech award…
Myocardial infarction and ischemic stroke are the most frequent causes of death or disability worldwide. Due to their ability to dissolve blood clots, the thrombolytics are frequently…
Introduction of microfluidic mixing technique opens a new door for preparation of the liposomes and lipid-based nanoparticles by on-chip technologies that are applicable in a laboratory and…
Gadolinium (Gd)–based contrast agents are extensively used for magnetic resonance imaging (MRI). Liposomes are potential nanocarrier–based biocompatible platforms for development of new generations of MRI diagnostics. Liposomes…
Polysaccharides are important group of compounds used in pharmaceutical industry. Their utilization in formulation of potential nanomedicine drug carriers includes formulation of nanoparticles from polysaccharides itself, encapsulation…